Myasthenia gravis (MG) is a infrequent muscle-nerve disease characterized by bodily weakness and exhaustion. This condition occurs when the connection between the brain and the body's muscles is disrupted . This breakdown is typically due to antibodies attacking the junction where nerves and muscles meet – the neuromuscular synapse . Consequently

Ketoconazole serves as a leading antifungal compound. This potent treatment effectively affects a wide variety of fungal infections, making it a crucial weapon in the fight against these harmful conditions. Its ability to block ergosterol biosynthesis, a essential component of fungal cell membranes, results in significant impairment of fungal cells